Abiopharma

🔍 Spinelli Stephen M (Executive)

Company: NAPCO SECURITY TECHNOLOGIES, INC (NSSC)

Report Date: 2026-03-17

Detailed Transactions and Holdings:

• Acquired 13,972 shares of Common Stock at $10.02 per share (Direct)
  Date: 2026-03-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,900.00 | transaction_form_type: 4
• Sold 3,212 shares of Common Stock at $43.59 per share (Direct)
  Date: 2026-03-17 | Code: F | equity_swap_involved: 0 | shares_owned_after: 11,688.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 13,972 shares of Employee Stock Option (Right to Buy) at $10.02 per share (Derivative)
  Date: 2026-03-17 | Code: M | Expires: 2030-04-30 | Exercise: 2021-04-30 | equity_swap_involved: 0 | shares_owned_after: 9,980.00 | transaction_form_type: 4
• Holds 5,000 shares of Employee Stock Option (Right to Buy) at $26.94 per share (Derivative)
  Date: 2026-03-17 | Code: H | Expires: 2032-08-25 | shares_owned_after: 5,000.00 | Footnotes: F3

Footnotes:

• F1: Represents the number of shares withheld by the Reporting Person as a result of the cashless exercise of stock options, and used to pay the exercise price, in accordance with the 2012 Employee Stock Option Plan and stock option grant.
• F2: Reflects a net increase of 10,760 shares resulting from the cashless exercise of 13,972 stock options as reflected in this Form.
• F3: Exercisable, cumulatively, at 20% per year commencing August 25, 2022.